You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾和諾德(NVO.US)與生科公司Deep Apple簽訂8.1億美元減肥藥物授權協議
阿思達克 06-12 01:52
諾和諾德(NVO.US)周三表示,與生物科技公司Deep Apple Therapeutics合作,達成一項價值高達8.12億美元的協議,開發治療包括肥胖症在內的心臟代謝疾病的藥物。 公司表示,Deep Apple使用其基於人工智能的平台發現候選藥物,該平台篩選數十億種化合物的虛擬庫,以縮短藥物發現時間。根據協議,諾和諾德將獲得開發和商業化非腸促胰島素口服療法的全球獨家權利,該療法與其廣受歡迎的減肥和糖尿病藥物Wegovy和Ozempic屬於不同類別的藥物。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account